Announcements Trials
Browse Landscape

Phase

Phase 3 2

Status

Unknown 2

Sponsor Class

OTHER 3NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 2

Conditions

Colonic Neoplasms 70Rectal Neoplasms 67Colorectal Neoplasms 61Breast Neoplasms 26Pancreatic Neoplasms 15Head and Neck Neoplasms 13Neoplasm Metastasis 12Esophageal Neoplasms 11Squamous Cell Carcinoma of Head and Neck 10Unspecified Adult Solid Tumor, Protocol Specific 9Stomach Neoplasms 8Urinary Bladder Neoplasms 5Esophageal Squamous Cell Carcinoma 5Carcinoma, Renal Cell 5Carcinoma, Hepatocellular 5Adenocarcinoma Of Esophagus 5Ovarian Neoplasms 4Kidney Neoplasms 4Gallbladder Neoplasms 4Bile Duct Neoplasms 4Peritoneal Neoplasms 3Oropharyngeal Neoplasms 3Neoplasms 3Nasopharyngeal Neoplasms 3Lymphoma 3Hypopharyngeal Neoplasms 3Gastrointestinal Neoplasms 3Anus Neoplasms 3Uterine Cervical Dysplasia 2Salivary Gland Neoplasms 2

Interventions

Trastuzumab 2Paclitaxel 2Leucovorin 2Fluorouracil 2Carboplatin 2veliparib 1tipifarnib 1entinostat 1Vincristine 1Taxes 1Semaxinib 1Oxaliplatin 1Interleukin-12 Subunit p35 1Interleukin-12 1Floxuridine 1Etoposide 1Epirubicin 1Doxorubicin 1Cyclophosphamide 1Cisplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NIH × Neoplasms, Unknown Primary × Fluorouracil × Clear all
NCT00022178 2013-09-20

Combination Chemotherapy in Treating Patients With Metastatic Cancer of an Unknown Site of Origin

National Cancer Institute (NCI)

Phase 3 Unknown
Tumor-Agnostic

Neoplasms, Unknown Primary

NCT00003558 2013-08-07

Chemotherapy in Treating Patients With Cancer of Unknown Primary Origin

National Cancer Institute (NCI)

Phase 3 Unknown
140 enrolled
Tumor-Agnostic

Neoplasms, Unknown Primary

Data powered by HemOnc (CC BY 4.0) Colophon âš¡